IDH1 and cancer: Interestingly, Beiko et al.9 reported that maximal surgical resection, including resection of both CE and non-CE areas, only contributed to improved survival in patients with IDH1-mutant malignant astrocytic tumors, but not IDH1 wild-type tumors.